Anteotech Ltd
ASX:ADO
Anteotech Ltd
ASX:ADO
Price:
0.021 AUD
-4.55%
Market Closed
Updated:
May 4, 2024
Anteotech Ltd
Operating Income
|
Anteotech Ltd
Operating Income Peer Comparison
Comparables:
PIQ
CTE
B
BPH
GSS
E
EZZ
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Anteotech Ltd
ASX:ADO
|
Operating Income
-AU$15.2m
|
CAGR 3-Years
-47%
|
CAGR 5-Years
-38%
|
CAGR 10-Years
-15%
|
|
|
Proteomics International Laboratories Ltd
ASX:PIQ
|
Operating Income
-AU$6m
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
N/A
|
|
|
Cryosite Ltd
ASX:CTE
|
Operating Income
AU$1.7m
|
CAGR 3-Years
26%
|
CAGR 5-Years
230%
|
CAGR 10-Years
5%
|
|
B
|
BPH Energy Ltd
ASX:BPH
|
Operating Income
-AU$1.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-66%
|
CAGR 10-Years
-8%
|
|
|
Genetic Signatures Ltd
ASX:GSS
|
Operating Income
-AU$18m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-40%
|
CAGR 10-Years
N/A
|
|
E
|
EZZ Life Science Holdings Ltd
ASX:EZZ
|
Operating Income
AU$6.4m
|
CAGR 3-Years
55%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Anteotech Ltd's Operating Income?
Operating Income
-15.2m
AUD
-15.2m
AUD
Based on the financial report for Dec 31, 2023, Anteotech Ltd's Operating Income amounts to -15.2m AUD.
What is Anteotech Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
-15%
-15%
Over the last year, the Operating Income growth was -11%. The average annual Operating Income growth rates for Anteotech Ltd have been -47% over the past three years , -38% over the past five years , and -15% over the past ten years .
You don't have any saved screeners yet
